Tempest Therapeutics
(NASDAQ) TPST
Tempest Therapeutics Financials at a Glance
Market Cap
$29.12M
Revenue (TTM)
$0.00
Net Income (TTM)
$36.05M
EPS (TTM)
$-10.10
P/E Ratio
-0.21
Dividend
$0.00
Beta (Volatility)
1.65 (High)
Dividend
$0.00
Beta (Volatility)
1.65 (High)
Price
$2.30
Volume
12,166
Open
$2.18
Price
$2.30
Volume
12,166
Open
$2.18
Previous Close
$2.30
Daily Range
$2.13 - $2.30
52-Week Range
$2.12 - $12.23
Dividend
$0.00
Beta (Volatility)
1.65 (High)
Price
$2.30
Volume
12,166
Open
$2.18
Previous Close
$2.30
Daily Range
$2.13 - $2.30
52-Week Range
$2.12 - $12.23
TPST News
TPST: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tempest Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
25
CEO
Stephen R. Brady
Website
www.tempesttx.comHeadquarters
Brisbane, CA 94080, US
TPST Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-405%
Return on Capital
-3%
Return on Assets
-2%
Earnings Yield
-4.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$29.12M
Shares Outstanding
13.48M
Volume
12.17K
Short Interest
0.00%
Avg. Volume
100.48K
Financials (TTM)
Gross Profit
$389.00K
Operating Income
$42.03M
EBITDA
$40.14M
Operating Cash Flow
$33.03M
Capital Expenditure
$435.00K
Free Cash Flow
$33.46M
Cash & ST Invst.
$30.27M
Total Debt
$15.37M
Tempest Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$66.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$29.12M
N/A
Market Cap/Employee
$1.21M
N/A
Employees
24
N/A
Net Income
$3.51M
+66.7%
EBITDA
$3.44M
+66.0%
Quarterly Fundamentals
Net Cash
$891.00K
-120.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$7.26M
-13.7%
Short Term Debt
$1.15M
-87.7%
Return on Assets
-2.10%
N/A
Return on Invested Capital
-2.68%
N/A
Free Cash Flow
$6.78M
+33.5%
Operating Cash Flow
$6.78M
+33.4%